A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.
Also called NCT01760447
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 223 participants
- Sponsor
- Registry
-
NCT01760447 -
2012-004035-23 -
2011-002529-23 -
2014-003583-20 -
CTRI/2012/09/003025
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01760447. Randomized; quadruple masking; primary purpose treatment. Start 2011-12-07 (actual); primary completion 2019-09-17 (actual). Results posted on 2020-10-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Sitagliptin plus metformin
- Intervention (Drug)
- Placebo to metformin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo to sitagliptin plus metformin
- Intervention (Drug)
- Sitagliptin plus metformin XR
- Intervention (Drug)
- Placebo to metformin XR
- Intervention (Drug)
- Insulin
- Intervention (Drug)
- Placebo to sitagliptin plus metformin XR
- Intervention (Drug)
- Metformin XR
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01760447- Content hash
4b98cb54a11977266cfb06f0e57899d549bb1a3a9b5bf72efbd4e6c5e46d0324